Global Patent Index - EP 3590519 A4

EP 3590519 A4 20201216 - GLP-1 SECRETAGOGUE AND COMPOSITION

Title (en)

GLP-1 SECRETAGOGUE AND COMPOSITION

Title (de)

GLP-1-SEKRETAGOG UND ZUSAMMENSETZUNG

Title (fr)

SÉCRÉTAGOGUE DE GLP -1 ET COMPOSITION

Publication

EP 3590519 A4 20201216 (EN)

Application

EP 18761539 A 20180226

Priority

  • JP 2017040867 A 20170303
  • JP 2018007005 W 20180226

Abstract (en)

[origin: EP3590519A1] The present invention addresses the problem of providing an exceptional GLP-1 secretagogue that is a component derived from milk, a composition for promoting GLP-1 secretion, and a food/beverage or drug containing the same. Any selected from the group consisting of micellar casein, a hydrolysate thereof, a fraction thereof, a purified product thereof, and peptides including an amino acid sequence indicated by any of SEQ ID NOS.: 1-7 is configured as an active ingredient of a GLP-1 secretagogue and a composition for promoting GLP-1 secretion.

IPC 8 full level

A61K 35/20 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61P 1/14 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP US)

A23L 2/66 (2013.01 - US); A23L 33/19 (2016.07 - US); A61K 35/20 (2013.01 - EP); A61K 38/018 (2013.01 - EP); A61K 38/08 (2013.01 - EP US); A61K 38/10 (2013.01 - US); A61P 1/14 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP)

Citation (search report)

  • [X] WO 2005081628 A2 20050909 - CHAY 13 MEDICAL RES GROUP N V [NL], et al
  • [XI] WO 2006068480 A2 20060629 - CAMPINA NEDERLAND HOLDING BV [NL], et al
  • [Y] EP 2489281 A1 20120822 - UNIV LIMERICK [IE]
  • [Y] US 2010305050 A1 20101202 - FITZGERALD DICK [IE], et al
  • [Y] CN 103275176 A 20130904 - UNIV TIANJIN COMMERCE
  • [XYI] ISABELLE M E LACROIX ET AL: "Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates", INTERNATIONAL DAIRY JOURNAL, ELSEVIER APPLIED SCIENCE, BARKING, GB, vol. 25, no. 2, 19 January 2012 (2012-01-19), pages 97 - 102, XP028490242, ISSN: 0958-6946, [retrieved on 20120210], DOI: 10.1016/J.IDAIRYJ.2012.01.003
  • [A] QI W ET AL: "Pepsin-Induced Changes in the Size and Molecular Weight Distribution of Bovine Casein During Enzymatic Hydrolysis", JOURNAL OF DAIRY SCIENCE, AMERICAN DAIRY SCIENCE ASSOCIATION, US, vol. 90, no. 11, 1 November 2007 (2007-11-01), pages 5004 - 5011, XP026956249, ISSN: 0022-0302, [retrieved on 20071101]
  • [A] ARYA M. SHARMA: "Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?", HYPERTENSION, vol. 44, no. 1, 1 July 2004 (2004-07-01), US, pages 12 - 19, XP055743233, ISSN: 0194-911X, DOI: 10.1161/01.HYP.0000132568.71409.a2
  • See references of WO 2018159546A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 3590519 A1 20200108; EP 3590519 A4 20201216; AU 2018227125 A1 20191024; CN 110381964 A 20191025; JP 7157043 B2 20221019; JP WO2018159546 A1 20191226; US 2019381128 A1 20191219; WO 2018159546 A1 20180907

DOCDB simple family (application)

EP 18761539 A 20180226; AU 2018227125 A 20180226; CN 201880015705 A 20180226; JP 2018007005 W 20180226; JP 2019502983 A 20180226; US 201816490673 A 20180226